-

Neogen® Announces Two Senior Leadership Appointments

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) today announced the appointments of Joe Freels as Senior Vice President and Chief Commercial Officer, effective January 5, 2026, and Dr. Tammi Ranalli as Senior Vice President and General Manager, Global Food Safety, effective January 7, 2026.

As Senior Vice President and General Manager for Neogen’s Food Safety business unit, Dr. Ranalli will have full P&L responsibility for Neogen’s global Food Safety portfolio and will develop and execute the global strategy for continued innovation and growth, including marketing, research and development, and government and regulatory affairs. She joins Neogen from QuidelOrtho, where she served as Senior Vice President and General Manager for the company’s molecular diagnostics and point-of-care business units.

As Senior Vice President and Chief Commercial Officer, Mr. Freels will lead Neogen’s global Food Safety commercial strategy, including sales, customer and technical services, regional marketing, and global commercial excellence. He brings more than 20 years of experience across diagnostics, life sciences, and healthcare, most recently serving as Senior Vice President, Global Commercial Operations at Cepheid.

“Tammi and Joe are both exceptional leaders, and we are pleased to welcome them to Neogen,” said Mike Nassif, President and Chief Executive Officer of Neogen. “Their combined commercial, scientific, and operational expertise will be instrumental as we continue to strengthen our Food Safety business and support our customers around the world.”

About Neogen

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

Contacts

IR@Neogen.com

Industry:

Neogen Corporation

NASDAQ:NEOG
Release Versions
English

Contacts

IR@Neogen.com

More News From Neogen Corporation

Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following...

Neogen Announces Second-Quarter 2026 Results

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) announced today the results of the second quarter ended November 30, 2025. “I am exceptionally proud of the Neogen team as we have initiated the first phase of our strategic transformation with early work focused on stabilizing and strengthening our core business. While it is early in the process, and our industry is currently seeing macro headwinds, our team drove significant sequential improvement in core revenue growth and pr...

Neogen Announces Second-Quarter Earnings Release Date

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its second-quarter earnings release before the opening of the market on January 8, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results. The conference call can be accessed by dialing: Toll-Free - North America: 1-800-549-8228 International: (+1) 646-564-2877 Conference ID: 82072 The live webcast can be acce...
Back to Newsroom